Voriconazole is inferior to amphotericin B deoxycholate as the initial induction therapy for HIV-associated Talaromyces marneffei fungemia: A multicenter retrospective study
Voriconazole is inferior to AmBd as an initial induction therapy for HTMF patients. Early AmBd administration or an early iVori→AmBd switch improves survival, despite the higher incidence of AmBd-related ADRs.
Authors
- Guanjing Lang
- Xingguo Miao
- Mengyan Wang (ORCID: https://orcid.org/0000-0002-8813-2555)
- Jiaying Qin (ORCID: https://orcid.org/0000-0001-5949-1041)
- Shasha Ye
- Lijun Xu (ORCID: https://orcid.org/0000-0001-7352-2086)
- Gong Chen (ORCID: https://orcid.org/0000-0002-1807-2067)
- Feifei Su (ORCID: https://orcid.org/0000-0001-9816-1491)
Institutions
- Zhejiang Chinese Medical University (CN)
- Wenzhou Central Hospital (CN)
- Hangzhou Xixi hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- PLoS neglected tropical diseases
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1371/journal.pntd.0013012
- Citations
- 2
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Chongqing Municipality Key Research and Development Program of China